WASHINGTON (dpa-AFX) - IDEXX Laboratories Inc. (IDXX) announced Friday that the Commissioners of the U.S. Federal Trade Commission or 'FTC' have preliminarily approved the consent agreement previously reached between the Company and the staff of the FTC Bureau of Competition.
Pursuant to FTC protocol, a proposed draft complaint and the proposed consent agreement, which includes a draft consent order, will be placed on public record for a 30-day comment period, after which the FTC will evaluate any public comment before finalizing the agreement and order.
Copyright RTT News/dpa-AFX